Utah Retirement Systems’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,300
Closed -$384K 1015
2022
Q1
$384K Buy
3,300
+100
+3% +$11.7K 0.01% 863
2021
Q4
$482K Hold
3,200
0.01% 861
2021
Q3
$382K Hold
3,200
0.01% 874
2021
Q2
$312K Buy
3,200
+100
+3% +$8.92K ﹤0.01% 905
2021
Q1
$274K Hold
3,100
﹤0.01% 883
2020
Q4
$297K Buy
3,100
+600
+24% +$61.8K ﹤0.01% 857
2020
Q3
$284K Buy
2,500
+100
+4% +$10.5K ﹤0.01% 865
2020
Q2
$237K Buy
+2,400
New +$192K ﹤0.01% 927

Other funds holding TNDM

Utah Retirement Systems's TNDM Position: Q2 2022 in Review

Utah Retirement Systems sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 3,300 shares — an estimated $384K sold.

Utah Retirement Systems first reported a position in TNDM in Q2 2020 and held it in 8 quarters. The position peaked at $482K in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Utah Retirement Systems reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Utah Retirement Systems sold 3,300 Tandem Diabetes Care shares in Q2 2022, an estimated $384K.
  • Utah Retirement Systems first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 8 quarters.
  • Utah Retirement Systems's Tandem Diabetes Care position peaked at $482K in Q4 2021.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Utah Retirement Systems's 13F filing for Q2 2022, filed 16 Aug 2022.